Meet our senior team
Nawab Qizilbash, MBChB MRCP (UK) BSc MSc DPhil (Coxon.)
Senior Clinical Epidemiologist and Head of OXON and:
• Honorary Associate Professor, London School of Hygiene and Tropical Medicine, London University
• Honorary Consultant Geriatrician, Hospital Cantoblanco, Madrid
• Member of Green Templeton College, Oxford University
• Co-author of x7 Lancet, x1 AMA and x3 BMJ publications in epidemiology, pragmatic trials and meta-analysis
• Chief editor of ‘Evidence-based Dementia Practice’ published by Blackwells, Oxford.
Nawab was Director of Epidemiology and Evidence-based Medicine, GSK (1997-2005); he trained under and worked with Professor Sir Richard Peto F.R.S., and was founding editor of the Cochrane Dementia Group. He also trained in general internal medicine and geriatrics under Professor Sir John Grimley Evans and was Honorary Consultant Physician at the Radcliffe Infirmary, Oxford (1997-2000), and St’s Mary’s Hospital, London (2005-2006).
He was the originator of the Prospective Studies Collaboration: individual participant data meta-analysis of 61 of the largest prospective cohort studies from 4 continents.
Among CROs in Europe, Nawab provides clients with a unique combination of high quality epidemiological and clinical experience (honorary consultant physician – “board-certified” equivalent in the USA) covering many therapeutic areas. He has sat on many Steering/Scientific committees as an expert in clinical epidemiology.
Steve Albrecht, BSc
Director of Global Strategic Development
Steve Albrecht, has over 29 years of operational experience directing observational studies including compassionate use. He was most recently Global Head of Late Phase for Chiltern International based in London, UK. He has been involved in directing over 150 observational studies including large global registries and retrospective chart studies.
Lorenzo Domínguez, MD MPH
Director of Operations
Lorenzo is a medical doctor and epidemiologist with more than 20 years of experience in conducting observational studies in all major therapeutic areas in Europe.
Lorenzo previously worked as an epidemiologist at AstraZeneca and the global CRO, SGS.
Ignacio Méndez, VMD MPH
Director of Field Analytics & HEOR
Ignacio has more than 19 years of experience in epidemiology, health economics, patient-reported outcomes and associated statistical methodologies.
He specialises in the application and analysis of PROs and health economic measures in observational studies and decision analysis. Ignacio has previously worked at the CRO, TAIS. He is currently a member of the ENCePP HTA task force of the EMA. He provides advanced statistical expertise and has experience of analysing safety data in observational studies.
Marta Mariño, BSc
Pharmacovigilance Director
Marta was previously head of pharmacovigilance at Schering-Plough from 1995-2010 and has experience of all areas and phases of drug safety. She has specialised in the operational, quality and compliance aspects of safety in observational studies and patient registries.
She ensures quality and compliance of all the quantitative safety projects in OXON.
Raúl Sánchez, BSc MSc
Director of Data ManagementRaúl has over 22 years of experience in data management using different EDC and paper-based systems in local and international projects in most of the indications. Raúl has previously worked as data manager, SAS programmer, project manager and director of the data management department at Sotio and CROs: ICON and MDS.
Our Consultants
Our expertise is further boosted by renowned Consultants
(close collaborators on retainers) for involvement in projects as necessary
STATISTICS
Stuart Pocock, MA PhD, is an eminent medical statistician (>30 NEJM, >40 Lancet) and Professor of Medical Statistics at the London School of Hygiene & Tropical Medicine. He has experience in epidemiology, trials and statistical methodology, including meta-analysis and EMA and FDA. He provides OXON advice on advanced analysis.
CLINICAL
Jeffrey Aronson, MA DPhil FRCP HonFBPhS HonFFPM, Honorary Consultant Physician and Clinical Pharmacologist, Oxford; President Emeritus of the British Pharmacological Society; Editor of Meyler’s Side Effects of Drugs, 16th edition; a member of the Advisory Board of the British National Formulary; and a former member